—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Immunovant Inc (IMVT) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 29 out of 100 (momentum 41 · quality 1 · valuation 4), as of 2026-11-04.
  • Signal: Mixed moving-average stack — Trades -14.5% vs the 50-day and -9.4% vs the 200-day average, 36.1% below the 52-week high and +35.5% off the 52-week low. Computed from daily closes. (as of 2026-11-03)
  • Trend: Immunovant Inc trades 14.5% below its 50-day and 9.4% below its 200-day moving average. (as of 2026-11-03)

Immunovant is a clinical-stage biotechnology company that develops antibody therapies for autoimmune diseases. Its main candidate blocks the neonatal receptor that recycles antibodies in the body, a mechanism aimed at conditions such as Graves' disease, myasthenia gravis and lupus-related skin disease.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the IMVT overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Mixed moving-average stack

Trades -14.5% vs the 50-day and -9.4% vs the 200-day average, 36.1% below the 52-week high and +35.5% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the IMVT chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on IMVT?

Mixed moving-average stack — Trades -14.5% vs the 50-day and -9.4% vs the 200-day average, 36.1% below the 52-week high and +35.5% off the 52-week low. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is IMVT above its 50-day and 200-day moving averages?

As of 2026-11-03, Immunovant Inc trades -14.5% below its 50-day and -9.4% below its 200-day average, with the 20-day +0.5% away.

How far is IMVT from its 52-week high?

36.1% below the 52-week high and 35.5% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.